Suchergebnisse - "Bhatnagar, Vishal"

PubPharm (70)

1

Facets of physical function assessed by patient-reported outcome measures in oncology research

enthalten in: Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation | 2024

von Coles, T. | Fillipo, R. | Plyler, K. | +11

2

What facets of physical function are most important to adults diagnosed with cancer?

enthalten in: Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation | 2024

von Coles, T. | Plyler, K. | Hernandez, A. | +10

3

Recommendations to address respondent burden associated with patient-reported outcome assessment

enthalten in: Nature medicine | 2024

von Aiyegbusi, O. | Cruz Rivera, S. | Roydhouse, J. | +37

4

Patient-reported frailty phenotype (PRFP) vs. International Myeloma Working Group frailty index (IMWG FI) proxy : A comparison between two approaches to measuring frailty

enthalten in: Journal of geriatric oncology | 2024

von Murugappan, M. | King-Kallimanis, B. | Bhatnagar, V. | +7

5

LSTMCNN : A hybrid machine learning model to unmask fake news

enthalten in: Heliyon | 2024

von Dev, D. | Bhatnagar, V. | Bhati, B. | +2

6

Considering Functional Outcomes as Efficacy Endpoints in Pediatric Low-Grade Glioma Clinical Trials : An FDA Educational Symposium

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2024

von Fangusaro, J. | Avery, R. | Fisher, M. | +10

7

FDA Approval Summary : Olaparib in Combination With Abiraterone for Treatment of Patients With BRCA-Mutated Metastatic Castration-Resistant Prostate Cancer

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2024

von Fallah, J. | Xu, J. | Weinstock, C. | +20

8

Integrating 4 methods to evaluate physical function in patients with cancer (In4M) : protocol for a prospective cohort study

enthalten in: BMJ open | 2024

von Thanarajasingam, G. | Kluetz, P. | Bhatnagar, V. | +18

UpdateOf: medRxiv. 2023 Mar 09;:. - PMID 36945495

9

Use of patient-reported outcomes (PRO) data to complement exposure-response analysis in early clinical cancer drug development

enthalten in: Journal of patient-reported outcomes | 2023

von Xia, H. | Booth, B. | Wang, Y. | +4

10

Use of patient-reported outcomes (PRO) data to complement exposure–response analysis in early clinical cancer drug development

enthalten in: Journal of patient-reported outcomes | 2023

von Xia, H. | Booth, B. | Wang, Y. | +4

1
2
3
4
5
6
7
Nächster »
[7]